Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

India Globalization Capital Inc (IGC)

India Globalization Capital Inc (IGC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,088
  • Shares Outstanding, K 51,038
  • Annual Sales, $ 900 K
  • Annual Income, $ -8,810 K
  • 60-Month Beta 3.35
  • Price/Sales 88.09
  • Price/Cash Flow N/A
  • Price/Book 2.47
Trade IGC with:

Options Overview Details

View History
  • Implied Volatility 99.09%
  • Historical Volatility 43.56%
  • IV Percentile 8%
  • IV Rank 6.95%
  • IV High 339.61% on 02/10/21
  • IV Low 81.14% on 07/21/21
  • Put/Call Vol Ratio 0.14
  • Today's Volume 388
  • Volume Avg (30-Day) 723
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 9,173
  • Open Int (30-Day) 12,169

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4700 +4.08%
on 09/16/21
1.7300 -11.56%
on 09/08/21
-0.1100 (-6.71%)
since 08/24/21
3-Month
1.3601 +12.49%
on 07/19/21
4.6500 -67.10%
on 07/22/21
-0.1200 (-7.27%)
since 06/24/21
52-Week
1.0100 +51.49%
on 09/25/20
4.6500 -67.10%
on 07/22/21
+0.4800 (+45.71%)
since 09/24/20

Most Recent Stories

More News
Pre-Market Brief: U.S. Stocks Set to Open Weaker

Morning Markets Sep S&P 500 futures this morning are down -0.13%. Stock futures are moving lower today on negative carry-over from a slide in European stocks on concern the ECB is getting ready to slow...

FTFT : 2.12 (-7.42%)
MARA : 36.18 (-4.03%)
BTBT : 9.46 (-2.27%)
COIN : 231.82 (-2.39%)
RIOT : 27.93 (-4.97%)
ADI : 178.53 (+0.73%)
ALB : 226.40 (-1.20%)
CTXS : 110.19 (-0.87%)
MCFE : 22.34 (+2.06%)
IGC : 1.5300 (-1.29%)
BMBL : 53.50 (-3.27%)
PHM : 47.49 (+0.27%)
IGC Reports Financial Results for the June 30, 2021, Quarter

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ended June 30, 2021.

IGC : 1.5300 (-1.29%)
IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC

India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office ("USPTO") issued a patent (#11,065,225) for the...

IGC : 1.5300 (-1.29%)
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer's Patients

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announces today it has completed Cohort 3 of its Phase 1 clinical trial on IGC's tetrahydrocannabinol ("THC")-based investigational...

IGC : 1.5300 (-1.29%)
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the Fiscal Year Ended March 31, 2021.

IGC : 1.5300 (-1.29%)
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits

/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana...

RTSL : 0.2400 (+0.04%)
TLRY : 11.67 (-2.91%)
TLRY.TO : 14.78 (-2.89%)
CRON : 5.70 (-5.00%)
CRON.TO : 7.21 (-5.13%)
ZYNE : 4.46 (-1.55%)
IGC : 1.5300 (-1.29%)
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

India Globalization Capital, Inc. ("IGC") (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC's tetrahydrocannabinol ("THC")-based investigational new...

IGC : 1.5300 (-1.29%)
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announces today that it has completed Cohort 1 of its Phase 1 clinical trial testing the IGC's tetrahydrocannabinol ("THC")-based...

IGC : 1.5300 (-1.29%)
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain

India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) announced today that on March 2, 2021, the Company received one more patent (patent#10,933,082) from the United States Patent and...

IGC : 1.5300 (-1.29%)
Update On IGC's Phase 1 Clinical Trial on Alzheimer's Patients

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to...

IGC : 1.5300 (-1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company's patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate...

See More

Key Turning Points

3rd Resistance Point 1.5900
2nd Resistance Point 1.5700
1st Resistance Point 1.5500
Last Price 1.5300
1st Support Level 1.5100
2nd Support Level 1.4900
3rd Support Level 1.4700

See More

52-Week High 4.6500
Fibonacci 61.8% 3.2595
Fibonacci 50% 2.8300
Fibonacci 38.2% 2.4005
Last Price 1.5300
52-Week Low 1.0100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar